Dr. Reddy''s Laboratories Limited has informed the Exchange that the Annual Report in Form 20F for the fiscal year ended March 31, 2026 has been filed with United States Securities and ....
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Reddy's Laboratories has informed exchanges that its Annual Report in Form 20-F for fiscal year ended March 31, 2026 was filed with the US Securities and Exchange Commission on May 30, 2026. The report contains annual consolidated financial statements prepared under International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board. The company is listed on NSE (DRREDDY), BSE (500124), NYSE (RDY), and NSE IFSC Ltd. This disclosure is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This is a routine regulatory compliance filing confirming the company has met its statutory reporting requirements with both Indian and US regulators. The filing indicates normal operational progress with no material deviations from expected disclosure timelines. Shareholders on all exchanges can now access the comprehensive annual report.